{
    "clinical_study": {
        "@rank": "136100", 
        "arm_group": [
            {
                "arm_group_label": "Urell", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Evaluation of the effect of URELL consumption on the occurrence of recurrent urinary tract\n      infection (Acute cystitis, pyelonephritis and asymptomatic bacteriuria)."
        }, 
        "brief_title": "Urell and Pregnancy", 
        "condition": "Urinary Tract Infection (UTI)", 
        "condition_browse": {
            "mesh_term": "Urinary Tract Infections"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - Pregnant woman in her 4th gestational month or more, having urinary tract infection.\n\n        Exclusion Criteria:\n\n          -  Pregnant woman with organic or functional urinary tract malformations\n\n          -  Diabetic patients\n\n          -  HIV positive"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "11", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01818180", 
            "org_study_id": "2009/19"
        }, 
        "intervention": [
            {
                "arm_group_label": "Urell", 
                "intervention_name": "URELL", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Suresnes", 
                    "country": "France", 
                    "zip": "92150"
                }, 
                "name": "H\u00f4pital FOCH"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of URELL(Cranberry Vaccinium Macrocarpon)Consumption on the Prevalence of Recurrent Urinary Tract Infection and Asymptomatic Bacteriuria During Pregnancy.", 
        "overall_official": {
            "affiliation": "H\u00f4pital FOCH  40, rue Worth 92150 Suresnes", 
            "last_name": "Jean Marc AYOUBI, PU-PH", 
            "role": "Study Chair"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "France : Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des Produits de Sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Recurrence of Urinary tract infections", 
            "safety_issue": "No", 
            "time_frame": "From the 4th gestational month till the end of pregnancy (about the 40th gestational week)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01818180"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Hopital Foch", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hopital Foch", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Double Blind (Subject, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}